Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-24-000071

Chief Operating Officer sold 11,551 shares at $17.55 ($202,720)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jarrett Jennifer · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-03-27 Sale : show line 1 in the form 10b5-1 −11,551 $17.55 $202,720 215,253 D
Open-market sales · 11,551 sh · avg $17.55 · $202,720
Loading xslF345X05/wk-form4_1711743618.xml…